Tag: VEITHsymposium 2016
VeClose trial indicates 24-month non-inferiority of VenaSeal versus radiofrequency ablation
Two-year outcomes of the VeClose pivotal trial have been reported, showing a 94.3% closure rate and “continued non-inferiority results to radiofrequency ablation” when using...
MOCA effective for greater saphenous vein insufficiency out to three years
A Dutch study of greater saphenous vein insufficiency patients has found that mechanochemical ablation (MOCA; ClariVein, Vascular Insights) is an effective and safe treatment...